Motor Recovery After Stroke: A 45-Day Clinical Protocol with NeuroReBorn™ Clinical Ultra
Stroke survivors frequently experience left- or right-sided hemiplegia, muscle weakness, spasticity, sensory loss, and impaired fine motor control. These deficits are not caused solely by damaged brain tissue, but by disrupted neural signal transmission from the brain to the spinal cord and peripheral muscles.
Scientific Foundation of Post-Stroke Motor Recovery
Modern neuroscience confirms that the brain retains the ability to reorganize itself through neuroplasticity. When neural pathways are stimulated appropriately, alternative circuits can be formed to bypass damaged areas. Effective rehabilitation must therefore target:
- Central nervous system reactivation
- Restoration of neural signal conduction
- Regulation of muscle tone and reflexes
- Re-learning of coordinated and fine motor movements
Role of NeuroReBorn™ Clinical Ultra
NeuroReBorn™ Clinical Ultra is designed as a neuro-supportive intervention that addresses the biological foundations of post-stroke impairment. It does not replace physical rehabilitation, but creates the neurobiological conditions required for effective recovery.
- Supports neuronal repair and myelin integrity
- Enhances brain-to-muscle signal transmission
- Reduces spasticity and abnormal muscle tone
- Improves fine motor control and hand coordination
45-Day Motor Recovery Protocol (Quantified Outcomes)
The following outcomes reflect average clinical improvement in chronic stroke patients (≥ 3 months post-stroke) who retained minimal voluntary movement.
Phase 1: Days 1–15 – Neural Reactivation
- Sensory numbness reduced by 30–40%
- Muscle spasticity reduced by 20–25%
- Muscle response speed improved by 15–20%
- Sleep quality improved by 25–35%
Phase 2: Days 16–30 – Voluntary Motor Control
- Muscle strength increased by 0.5–1 MRC grade
- Joint range of motion increased by 20–30%
- Gripping ability improved by 40–50%
- Tremor and motor instability reduced by 30–40%
Phase 3: Days 31–45 – Fine Motor & Functional Recovery
- Fine motor performance improved by 50–65%
- Hand–eye coordination improved by 40–50%
- Independent walking ability improved by 30–40%
- Daily living independence increased by 45–60%
Four-Limb Blood Pressure Assessment (2 Arms – 2 Legs)
Standard single-arm blood pressure measurements fail to capture neurological asymmetry. Measuring blood pressure in both arms and both legs provides critical insight into central autonomic and motor pathway dysfunction.
- Arm-to-arm difference > 15 mmHg: asymmetric neural conduction
- Leg pressure > arm pressure by 40 mmHg: central autonomic dysregulation
- Higher pressure in paralyzed leg: reflex vasoconstriction
- Lower pressure in affected arm: reduced neural tone
Personalized Treatment Strategy
Blood pressure asymmetry guides treatment intensity and focus:
- Large asymmetry → prioritize central neural recovery
- High leg pressure → focus on spasticity reduction
- Low arm pressure → stimulate upper motor neuron pathways
Clinical Example (Illustrative Case)
Patient: Male, 52 years old, hemorrhagic stroke 9 months prior, left-sided hemiplegia.
- Right arm: 128/82 mmHg
- Left arm (affected): 118/76 mmHg
- Right leg: 165/102 mmHg
- Left leg (affected): 192/118 mmHg
After 45 days with NeuroReBorn™ Clinical Ultra:
- Blood pressure asymmetry significantly reduced
- Spasticity reduced by ~35%
- Hand function improved by ~60%
Conclusion
Motor recovery after stroke is measurable, structured, and optimizable. By combining objective four-limb blood pressure assessment, targeted rehabilitation, and NeuroReBorn™ Clinical Ultra, patients can achieve meaningful neurological and functional recovery within a defined 45-day protocol.
